Pathologie approach to the diagnosis of vasculitis

Current Diagnostic Pathology

Volumn 5, Issue 2, 1998, Pages 70-81

  Cavallo, T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004990541     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(98)80011-2     Document Type: Article

References (50)

1. Jennette J C, Falk R J, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
2. Lie J T. Biopsy diagnosis of systemic vasculitis. Baillieres Clin Rheumatol 1997; 11:219-236.
3. Kassirer J P. Diagnosis in the public domain. N Engl J Med 1993;329:50-51.
4. van der Woude F J, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease acitivity in Wegener's granulomatosis. Lancet 1985; 1: 425-429.
5. Falk R J, Jennette J C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657.
6. Falk R J, Jennette J C. ANCA small-vessel vasculitis. J Am Soc Nephrol 1997; 8: 314-322.
7. Kallenberg, C G M, Brouwer B, Weening J J et al. Antineutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15.
8. Charles L A, Falk R J, Jennette J C. Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes. J Leuk Biol 1992;51:65-68.
9. Calafat J, Goldshmeding R, Ringeling P L et al. In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes. Blood 1990; 75: 242-250.
10. Charles L A, Caldas M L R, Falk R J et al. Antibodies against granule proteins activate neutrophils in vitro. J Leuk Biol 1991; 50: 539-546.
11. Mayet W J, Csernok B, Szymkowiak C et al. Human endothelial cells express proteinase 3, the target antigen of anti-cytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82: 1221-1229.
12. Jennette J C, Falk R J. The coming of age of sérologie testing for anti-neutrophil cytoplasmic autoantibodies. Mayo Clin Proc 1994; 69:908-910.
13. Weiss S J. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-376.
14. Belizna C, Tervaert J W. Specificity, pathogenicity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum 1997; 2: 98-109.
15. Jennette C J, Milling D M, Falk R J. Vasculitis affecting the skin. A review. Arch Dermatol 1994; 130: 899-906.
16. Sneller M C, Fauci A S. Pathogenesis of vasculitis syndromes. Adv Rheumatol 1997; 81: 221-242.
17. Bush T M. Systemic vasculitis. Diagnostic clues to this confusing array of diseases. Postgrad Med 1998; 103: 68-86.
18. Lie J T. Vasculitis associated with infectious agents. Curr Opin Rheumatol 1996; 8:26-29.
19. Schmitt W H, Gross W L. Vasculitis in the seriously ill patient: Diagnostic approaches and therapeutic options in ANCAassociated vasculitis. Kidney Int 1998; 53(Suppl 64): S39-S44.
20. Lie J T. Classification and histopathologic spectrum of central nervous system (CNS) vasculitis. Neurol Clin 1997; 15: 805-819.
21. Hoffman G S, Kerr G S, Leavitt R Y et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-4498.
22. Cohen Tervaert J W, van der Woude F J, Fauci A S et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149:2461-2465.
23. Weber M F A, Andrassy K, Pullig O et al. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol 1992; 2: 1227-1234.
24. Gaudin P B, Askin F B, Falk R J, Jennette J C. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995; 104: 7-16.
25. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
26. Savage COS, Winearls C G, Evans D J et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56:467-483.
27. Merkel P A. Drugs associated with vasculitis. Curr Opin Rheumatol 1998; 10:45-50.
28. Tervaert J W C, Stegeman C A, Kallenberg C G M. Silicon exposure and vasculitis. Curr Opin Rheumatol 1998; 10: 12-17.
29. Jennette J C, Falk R J. Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies. Lab Invest 1994; 70: 135-137.
30. Bosch X, Mirapeix E, Font J et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991; 36: 107-113.
31. Barron K S. Kawasaki disease in children. Curr Opin Rheumatol 1998; 10:29-37.
32. Habib R, Niaudet P, Levy M. Schönlein-Henoch purpura ephritis and IgA nephropathy. In Renal Pathology with Clinical and Functional Correlations. C C Tisher, B M Brenner, editors. J B Lippincott Company: Philadelphia 1994,472-523.
33. Martin S J, Audrain M A, Baranger T, Moreau A, Dantal J, Testa A, Esnault V L. Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation. Am J Kidney Dis 1997; 29: 125-131.
34. Montinaro V, Esparza A R, Cavallo T et al. Antigen as mediator of glomerular injury in experimental IgA nephropathy. Lab Invest 1991;64:508-519.
35. Agnello V, Chung R T, Kaplan L M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
36. Dammaco F, Sansonno D. Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 1997; 15: 97-119.
37. Drenkard C, Villa A R, Reyes E et al. D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6: 235-242.
38. Schnabel A, Csernok E, Isenberg D A et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 633-637.
39. Danning C L, Illei G G, Boumpas D T. Vasculitis associated with primary rheumatologic diseases. CUIT Opin Rheumatol 1998; 10:58-65.
40. Scott D GI, Bacon P A, Tribe D R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine 1981; 60: 288-297.
41. Patel A, Prussick R, Buchanan W W et al. Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol 1991; 24: 652-653.
42. Sanchez-Guerrero J, Gutierrez-Urena 5, Vidaller A et al. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol 1990; 17: 1458-1462.
43. Cohen P R, Kurzrock R. Mucocutaneous paraneoplastic syndromes. Sem Oncol 1997; 24:334-359.
44. Giger U, Werner L L, Millichamp N J et al. Sulfadiazine-induced allergy in six Doberman pinschers. J Am Vet Med Assoc 1985; 186:479-4184.
45. Jorizzo J L, Hudson R D, Schmalstieg F C et al. Behcet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol 1984; 10: 205-214.
46. Jennette J C, Charles L A, Falk R J. The neutrophil and its role in systemic vasculitis. In The Biologie Basis of Systemic Vasculitis. E C Le Roy, editor. Marcel Dekker, Inc.: NewYork, 1992,65-92.
47. Gross W L, Schmitt W H, Csemok E. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis 1991; 18: 175-179.
48. Guillevin L, Visser H, Nöel L H et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol 1993; 20: 1345-1349.
49. Guillevin L, Lhote F, Cohen P et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 1995; 74: 238-253.
50. Olin J W. Thromboangiitis obliterans. Curr Opin Rheumatol 1994; 6:44-49.